Kite Pharma, Inc. Revenue
Kite Pharma, Inc. reported Revenue of $10.05 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2017-08-08
- Kite Pharma, Inc. revenues for the quarter ending 2017-06-30 was $10.05M, a 109.64% increase year-over-year.
- Kite Pharma, Inc. revenues for the quarter ending 2017-03-31 was $9.84M, a 91.85% increase year-over-year.
- Kite Pharma, Inc. revenues for the quarter ending 2016-12-31 was $4.91M, a 0.41% increase year-over-year.
- Kite Pharma, Inc. revenues for the quarter ending 2016-09-30 was $7.34M, a 44.31% increase year-over-year.
- Kite Pharma, Inc. revenues for fiscal 2016 was $22.17M, a 28.46% increase from fiscal 2015.
- Kite Pharma, Inc. revenues for fiscal 2015 was $17.26M.
- Kite Pharma, Inc. revenues for fiscal 2014 was $0.00.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2017-06-30 | $10.05M 10-Q · filed 2017-08-08 | $19.89M 10-Q · filed 2017-08-08 | $24.80M derived: sum of 3 quarters · filed 2017-08-08 | $32.14M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | $9.84M 10-Q · filed 2017-05-08 | $14.74M derived: sum of 2 quarters · filed 2017-05-08 | $22.08M derived: sum of 3 quarters · filed 2017-05-08 | $26.88M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-12-31 | $4.91M 10-K · filed 2017-02-28 | $12.25M derived: sum of 2 quarters · filed 2017-02-28 | $17.04M derived: sum of 3 quarters · filed 2017-08-08 | $22.17M 10-K · filed 2017-02-28 |
| 2016-09-30 | $7.34M 10-K · filed 2017-02-28 | $12.14M derived: sum of 2 quarters · filed 2017-08-08 | $17.26M 10-Q · filed 2016-11-09 | $22.15M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-06-30 | $4.79M 10-Q · filed 2017-08-08 | $9.92M 10-Q · filed 2017-08-08 | $14.81M derived: sum of 3 quarters · filed 2017-08-08 | $19.90M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $5.13M 10-Q · filed 2017-05-08 | $10.01M derived: sum of 2 quarters · filed 2017-05-08 | $15.10M derived: sum of 3 quarters · filed 2017-05-08 | $19.50M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | $4.89M 10-K · filed 2017-02-28 | $9.97M derived: sum of 2 quarters · filed 2017-02-28 | $14.38M derived: sum of 3 quarters · filed 2017-02-28 | $17.26M 10-K · filed 2017-02-28 |
| 2015-09-30 | $5.09M 10-K · filed 2017-02-28 | $9.49M derived: sum of 2 quarters · filed 2017-02-28 | $12.37M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $4.40M 10-K · filed 2017-02-28 | $7.28M 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $2.88M 10-K · filed 2017-02-28 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |